We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CWD:NASDAQCaliberCos Inc. Analysis

Data as of 2026-06-22 - not real-time

$0.75

Latest Price

9/10Risk

Risk Level: High

Executive Summary

CaliberCos Inc. is trading well below its 20‑day SMA (0.878) at $0.752, with the 20‑day SMA itself already under the 50‑day (0.989) and 200‑day (2.113) averages, signaling a prolonged bearish trend. The MACD histogram is negative and the signal line is labeled bearish, while the RSI sits at 36, suggesting limited upside momentum. Financial health is deeply compromised: operating margin is –64%, profit margin –123%, and the company carries $122 million of debt against a mere $0.9 million cash balance, yielding a debt‑to‑equity ratio above 315. The balance sheet weakness is compounded by a negative ROE of –106% and zero operating cash flow. Volatility is extreme at 85% over the past 30 days and beta is 2.75, indicating the stock moves sharply with market swings. Recent material news notes the departure of CFO Jade Leung, adding uncertainty to financial stewardship. Liquidity is deteriorating as volume trends downward and average daily volume exceeds current trading volume, raising concerns about the ability to enter or exit positions without price impact. Given the bearish technicals, distressed fundamentals, and heightened risk metrics, the outlook remains highly unfavorable in the near to medium term.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 8/10

Key Factors

  • Bearish technical indicators (price below SMA 20, negative MACD)
  • High volatility and beta amplifying price swings
  • CFO resignation adding short‑term uncertainty

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Sustained negative earnings and margins
  • Severe debt overhang with negligible cash
  • Continuing downward volume trend limiting liquidity

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Fundamental restructuring required to address balance‑sheet weakness
  • No dividend or cash generation to support valuation
  • Industry pressures on asset‑management firms and high sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth-40.90%
Profit Margin-122.65%
P/E Ratio-2.9
ROE-105.94%
ROA-3.40%
Debt/Equity315.59
P/B Ratio5.3
Industry P/E16.9

Technical Analysis

TrendBearish
RSI36.3
Support$0.73
Resistance$1.05
MA 20$0.88
MA 50$0.99
MA 200$2.11
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta2.75
Volatility85.28%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.